Document Detail

Extended-spectrum beta lactamase-producing gram-negative bacteria: clinical profile and outcome in a neonatal intensive care unit.
MedLine Citation:
PMID:  17469732     Owner:  NLM     Status:  MEDLINE    
BACKGROUND & AIMS: Multidrug-resistant extended-spectrum 3 lactamase-producing bacteria (ESBL) have emerged as a common problem globally. However, data regarding clinical profile and outcome in neonates infected with ESBL-producing gram-negative bacteria are sparse. METHODS: A retrospective study was undertaken of all neonates admitted between April 2002 and May 2003 to the neonatal intensive care unit, Safdarjang Hospital, New Delhi who had blood cultures positive for gram-negative bacteria. The clinical profile and outcome in each patient was obtained from the case notes. The mortality and morbidity of the ESBL (cases) and non-ESBL groups were compared. Data were analysed using the chi(2) and Student's t-tests. RESULTS: There were 75 cases of gram-negative septicaemia, 46 newborns (61.3%) were infected with ESBL-producing strains and 63 case records were available. ESBL production was associated with prematurity (24/38 vs 9/25, p=0.03), prolonged rupture of membranes (14/38 vs 2/25, p=0.01) and previous antibiotic administration to the infant (15/38 vs 1/25, p=0.002). Fifty per cent of infants with early-onset sepsis and 82.1% with late-onset sepsis were infected with ESBL strains. Newborns with ESBL sepsis were more likely to manifest persistent thermal instability (13/38 vs 3/25, p=0.04) and pre-feed gastric aspirates (18/38 vs 3/25, p=0.004). More than 90% of ESBL isolates were susceptible to carbapenems, cefperazone-sulbactam and piperacillin-tazobactam. The mean length of nursery stay (15.8 vs 10.7, p=0.02) and mortality (23.6 vs 4.0%, p= 0.07) were higher in the ESBL group and onset of feeds was delayed (7.6 vs 3.9 days, p=0.007) in this group. CONCLUSIONS: Isolation of ESBL in cases of early-onset sepsis indicates that ESBL producers might have percolated into the community. Early suspicion of ESBL-producing isolates in cases of neonatal sepsis can facilitate prompt institution of appropriate empirical therapy and lead to an improved outcome.
Rachna Sehgal; Rajni Gaind; Harish Chellani; Pushpa Agarwal
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Annals of tropical paediatrics     Volume:  27     ISSN:  0272-4936     ISO Abbreviation:  Ann Trop Paediatr     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-05-01     Completed Date:  2007-07-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8210625     Medline TA:  Ann Trop Paediatr     Country:  England    
Other Details:
Languages:  eng     Pagination:  45-54     Citation Subset:  IM    
Departments of Pediatrics, Vardhman Mahavir Medical College and Safdarjang Hospital, New Delhi, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / administration & dosage
Cross Infection / etiology,  microbiology*
Drug Administration Schedule
Drug Resistance, Multiple, Bacterial
Gram-Negative Bacteria / drug effects,  enzymology*
Gram-Negative Bacterial Infections / etiology,  microbiology*
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases / microbiology
Intensive Care Units, Neonatal*
Length of Stay
Microbial Sensitivity Tests
Risk Factors
Sepsis / etiology,  microbiology
Survival Analysis
beta-Lactamases / biosynthesis*
Reg. No./Substance:
0/Anti-Bacterial Agents; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Oral bisphosphonate treatment for osteogenesis imperfecta--an Indian perspective.
Next Document:  The association between Helicobacter pylori infection and height in children from an urban community...